Anúncio
Anúncio
HUMA
Humacyte, Inc. Common Stock
1.17
USDPatrocinado
0.00
-0.34%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
1.18
+0.01
+0.77%
Relatórios de Lucros HUMA
Rácio de surpresa positiva
HUMA separação 12 de 19 últimas estimativas.
63%
Próximo Relatório
Data do Próximo Relatório
26 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.37M
/-$0.13
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+81.90%
/+18.18%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-18.75%
Humacyte, Inc. Common Stock earnings per share and revenue
On 12 de nov. de 2025, HUMA reported earnings of -0.11 USD per share (EPS) for Q3 25, beating the estimate of -0.16 USD, resulting in a 31.89% surprise. Revenue reached 753.00 mil, compared to an expected 940.78 mil, with a -19.96% difference. The market reacted with a -2.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analistas forecast an EPS of -0.13 USD, with revenue projected to reach 1.37 milhão USD, implying an aumentar of 18.18% EPS, and aumentar of 81.90% in Revenue from the last quarter.
FAQ
What were Humacyte, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Humacyte, Inc. Common Stock reported EPS of -$0.11, beating estimates by 31.89%, and revenue of $753.00K, -19.96% below expectations.
How did the market react to Humacyte, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.34%, changed from $1.28 before the earnings release to $1.25 the day after.
When is Humacyte, Inc. Common Stock expected to report next?
The next earning report is scheduled for 26 de mar. de 2026.
What are the forecasts for Humacyte, Inc. Common Stock's next earnings report?
Based on 8
analistas, Humacyte, Inc. Common Stock is expected to report EPS of -$0.13 and revenue of $1.37M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio